secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2026-05-11T23:59:59+00:00
Accession:  0001274737-26-000027
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen Q1 2026: Record revenue $17.3M, net loss $4.0M; FY guidance reaffirmed
-----------------------------------------------------------------------------

- Revenue rose 12% YoY to $17.3M; net loss widened to $4.0M from $3.8M.
- AVISE CTD test volume increased 10% YoY; TTM ASP rose 6% to $444.
- Adjusted EBITDA loss improved 14% to $2.2M; cash $21.5M, ahead of expectations.
- Full-year 2026 revenue guidance reaffirmed at $70M-$73M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473726000027/0001274737-26-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473726000027/exdx-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001274737-26-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer